Transthoracic defibrillation: effect of sternotomy on chest impedance

Predictors of Transthoracic Impedance in Patients Who Underwent Elective Electrical Cardioversion

Successful synchronized direct current cardioversion (DCCV) requires adequate current delivery to the heart. However, adequate current for successful DCCV has not yet been established. Transmyocardial current depends on 2 factors: input energy and transthoracic impedance (TTI). Although factors affecting TTI have been studied in animal models, factors affecting TTI in humans have not been well established. Herein, we explored the potential factors that affect TTI in humans. A retrospective review of patients who underwent DCCV at a large quaternary medical center between October 2019 and August 2021 was conducted. Pertinent clinical information, including demographics, echocardiography findings, laboratory findings, and body characteristics, was collected. Cardioversion details, including joules delivered and TTI, were recorded by the defibrillator for each patient's first shock. Predictors of thoracic impedance were assessed using regression analysis. A total of 220 patients (29% women) were included in the analysis; 143 of the patients (65%) underwent DCCV for atrial fibrillation and 77 (35%) underwent DCCV for atrial flutter. The mean impedance in our population was 73 ± 18 Ω. In a regression model with high impedance defined as the upper quartile of our cohort, body mass index (BMI), female sex, obstructive sleep apnea, and chronic kidney disease (all p values <0.05) were significantly associated with high impedance. According to a receiver operating characteristic analysis, BMI has a high predictive value for high impedance, with an area under the curve of 0.76. In conclusion, our study reveals that elevated BMI, female sex, sleep apnea, and chronic kidney disease were predictors of higher TTI. These factors may help determine the appropriate initial shock energy in patients who underwent DCCV for atrial fibrillation and flutter.

A Systematic Review of the Transthoracic Impedance during Cardiac Defibrillation

For cardiac defibrillator testing and design purposes, the range and limits of the human TTI is of high interest. Potential influencing factors regarding the electronic configurations, the electrode/tissue interface and patient characteristics were identified and analyzed. A literature survey based on 71 selected articles was used to review and assess human TTI and the influencing factors found. The human TTI extended from 12 to 212 Ω in the literature selected. Excluding outliers and pediatric measurements, the mean TTI recordings ranged from 51 to 112 Ω with an average TTI of 76.7 Ω under normal distribution. The wide range of human impedance can be attributed to 12 different influencing factors, including shock waveforms and protocols, coupling devices, electrode size and pressure, electrode position, patient age, gender, body dimensions, respiration and lung volume, blood hemoglobin saturation and different pathologies. The coupling device, electrode size and electrode pressure have the greatest influence on TTI.

Alteration in transthoracic impedance following cardiac surgery

INTRODUCTION

Haemodynamically significant ventricular tachyarrhythmias are a frequent complication in the immediate post-operative period after cardiac surgery. Successful cardioversion depends on delivery of sufficient current, which in turn is dependent on transthoracic impedance (TTI). However, it is uncertain if there is a change in TTI immediately following cardiac surgery using cardiopulmonary bypass (CPB).

METHODS

TTI was measured on 40 patients undergoing first time isolated cardiac surgery using CPB. TTI was recorded at 30 kHz using Bodystat Multiscan 5000 equipment before operation (with and without a positive end-expiratory pressure (PEEP) of 5 cm of H(2)O) and then at 1, 4 and 24 h after the operation. Data was analyzed to determine the relationship between pre- and post-operative variables and TTI values.

RESULTS

Mean pre-operative TTI was 54.5+/-10.55 ohms without PEEP and 61.8+/-15.4 ohms on a PEEP of 5 cm of H(2)O. TTI dropped significantly (p<0.001) after the operation to 47.2+/-10.6 ohms at 1 h, 42.6+/-10.2 ohms at 4 h and 41.8+/-10.4 ohms at 24 h. A positive correlation was noted between duration of operation and TTI change at 1 h (r=0.38; p=0.016). There was no significant correlation between the duration of bypass and change in TTI.

CONCLUSION

TTI decreases by more than 30% in the immediate post-operative period following cardiac surgery. This state may favour defibrillation at lower energy levels.

Electrical cardioversion of atrial fibrillation

External direct current cardioversion remains the most common and effective method for restoration of normal sinus rhythm in patients with persistent AF. The development of biphasic defibrillators allows for higher success rates of conversion using standard energy levels. For persistent AF, an initial energy of 200 J is recommended for biphasic defibrillators, and 300 to 360 J are recommended for monophasic defibrillators, with the electrodes placed in the anterior posterior position. For refractory cases, alternatives are available such as dual defibrillators or internal cardioversion. Antiarrhythmic drugs may enhance the results of cardioversion by helping overcome shock failure or by preventing immediate recurrence of AF. Thromboembolism is the most important complication associated with cardioversion, but it can be prevented by providing 3 weeks of anticoagulation before the procedure or by excluding the presence of thrombi by transesophageal echocardiography, followed by an additional 4 weeks of anticoagulation.

Effect of application of force to self-adhesive defibrillator pads on transthoracic electrical impedance and countershock success

STUDY OBJECTIVE

To examine the effect of the application of force to self-adhesive defibrillator pads on transthoracic electrical impedance and countershock success.

METHODS

A prospective, randomized, controlled pilot study was carried out in an experimental animal laboratory, involving 32 mixed-breed swine weighing 36.5 to 55.7 kg each. Ventricular fibrillation (VF) was induced, and the animals were randomly allocated to 1 of 4 groups, with 8 animals per group. Animals in groups I and II remained in VF for 30 seconds; those in groups III and IV remained in VF for 5 minutes. At the end of the VF period, up to 3 countershocks were given. In groups I and III, countershocks were delivered through the self-adhesive defibrillator pads alone; in groups II and IV, they were delivered through the defibrillator pads with 25 lb of applied force. Any animal without return of spontaneous circulation after 3 countershocks was given epinephrine after 1 minute of CPR, followed by 1 additional minute of CPR and 1 additional countershock if required.

RESULTS

The main measurements included baseline and countershock transthoracic impedance, cumulative countershock success rate, and 30-minute survival rate. Application of 25 lb of force to the defibrillator pads significantly decreased transthoracic impedance, compared with baseline values (group II, 15. 1% decrease; group IV, 16.1% decrease). The first-shock success rate was higher when force was applied during the countershock (87.5% versus 50% for groups II and I, respectively; 62.5% and 37.5% for groups IV and III, respectively). In the animals who experienced 5 minutes of VF, there were greater rates of success after the second, third, and fourth countershocks when force was applied (group IV) than when no force was applied (group III). Groups I and II (VF for 30 seconds) demonstrated 100% survival at 30 minutes. Group IV had a higher 30-minute survival rate (3/8 animals) than did group III (1/8). However, the rates of countershock success and 30-minute survival were not statistically different among the groups.

CONCLUSION

Application of force to self-adhesive defibrillator pads decreases transthoracic impedance during countershock. This effect may contribute to improving the countershock success rate.

Randomised comparison of electrode positions for cardioversion of atrial fibrillation

OBJECTIVE

To compare the relative efficacy of anteroanterior v anteroposterior electrode pad positions for external cardioversion of atrial fibrillation.

DESIGN

Prospective randomised trial.

SETTING

Tertiary referral cardiology centre in the United Kingdom.

PATIENTS

90 patients undergoing elective cardioversion for atrial fibrillation.

INTERVENTIONS

Cardioversion was attempted with self adhesive electrode pads with an area of 106 cm2 placed either in the anteroanterior (AA) or anteroposterior (AP) positions. Initial shock was 100 J which, if unsuccessful, was followed by 200 J, 300 J, and 360 J if required. Peak current and transthoracic impedance were measured.

MAIN OUTCOME MEASURES

Cardioversion success rate and energy requirements.

RESULTS

Cardioversion was successful in 81% of the patients (73/90). There was no statistically significant difference in the cardioversion success rate (AA 84%, 38/45 patients; AP 78%, 35/45 patients; p = 0.42) or mean (SD) energy requirement for all patients (AA 223 (96.1) J; AP 232 (110) J) or for patients who were successfully cardioverted (AA 197.9 (82.4) J; AP 195.4 (97.2) J; p = 0.9) between the two pad positions. The mean transthoracic impedance (TTI) for the first shock (AA 77.5 (18.4) ohms; AP 73.7 (18.7) ohms; p = 0.34) was not significantly different between the two groups. TTI correlated significantly with body mass index, percentage body fat, and chest AP diameter. There was a progressive decrease in TTI with serial shocks. While aetiology and TTI were the two independent significant predictive factors for energy requirement, duration of atrial fibrillation was the only independent predictor of cardioversion success in a multivariate analysis.

CONCLUSIONS

Electrode pad position is not a determinant of cardioversion success rate or energy requirement.

Atrial defibrillation. New frontiers

External electrical atrial defibrillation was developed in the early 1960s. Direct current electrical external shocks convert atrial fibrillation to sinus rhythm in the majority of patients. Although much has been learned about the mechanisms of the arrhythmia and those responsible for successful external direct current atrial defibrillation, the technique has remained essentially unchanged since it was first described by Lown and colleagues. Animal and human studies have shown that atrial defibrillation can be terminated by shocks delivered by way of internal electrode catheters. The technique is most effective when biphasic waveform shocks are delivered by way of large surface area electrodes in the right atrium and the coronary sinus. Synchronization of shocks to R waves greater than 500 msec after the previous beat prevents induction of ventricular tachyarrhythmias. Therefore, internal atrial defibrillation provides an effective and safe method for restoring sinus rhythm in patients who fail external direct current cardioversion. The success of the implantable cardioverter-defibrillator and the encouraging safety and efficacy data from studies of internal atrial defibrillation have generated considerable interest in developing an implantable atrial defibrillator. The efficacy of low-energy shocks to terminate the arrhythmia suggests that such a device might be tolerated by patients. Data about the pathogenesis of atrial fibrillation suggest that rapid detection and immediate termination of atrial fibrillation theoretically might prevent recurrence of the arrhythmia. These data support the development of an implantable atrial defibrillator and the initiation of clinical trials to determine its utility.

Transthoracic defibrillation: importance of avoiding electrode placement directly on the female breast

OBJECTIVES

This study sought to determine the effect on transthoracic impedance of placement of defibrillation electrodes on the female breast versus adjacent to or under the breast.

BACKGROUND

Transthoracic impedance is a major determinant of transthoracic current flow in defibrillation. For a given energy setting, a high transthoracic impedance reduces current flow and may adversely affect the ability of electric shocks to accomplish defibrillation. We hypothesized that the increased interelectrode tissue associated with placement of the apex defibrillation electrode on the female breast would result in increased transthoracic impedance compared with electrode placement lateral to or under the breast.

METHOD

Transthoracic impedance was measured noninvasively by passing a 5-V, 31.25-kHz square wave current through the chest and comparing the low level current flow to known references. We measured transthoracic impedance associated with three different apex defibrillation electrode positions--on the breast, under the breast and lateral to the breast--in 25 women (brassiere size 34A to 48C, 25 to 75 years old, body weight 128 to 328 lb [58 to 148 kg] and 2 men. The measurements were taken with a modified defibrillator that accurately predicts transthoracic impedance without delivering an actual shock. The measurement sequence was random.

RESULTS

The average measured transthoracic impedance with placement of the apex defibrillation electrode on the breast was 95 +/- 25 ohms (mean +/- SD), under the breast 84 +/- 17* ohms and lateral to the breast 83 +/- 20* ohms (asterisk indicates p < 0.01 vs. on the breast by analysis of variance). The study cohort was also classified into two groups: large breasted (brassiere size > or = 40) and small breasted (brassiere size < or = 39). The measured transthoracic impedances for the large-breasted group were 112 +/- 20 ohms for on the breast, 94 +/- 13* ohms for under the breast and 98 +/- 19* ohms for lateral to the breast. For the small breasted group, the similar transthoracic impedance measurements were 81 +/- 21, 77 +/- 16 and 71 +/- 13* ohms, respectively.

CONCLUSIONS

In women, placement of the apex defibrillation electrode on the breast results in higher transthoracic impedance, which will reduce current flow. We recommend placing the apex electrode lateral to or underneath the breast.

Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations

BACKGROUND

In previous studies, epicardial patch electrodes decreased transthoracic defibrillation efficacy. We studied the effects of two inactive epicardial 14-cm2 titanium mesh patches on defibrillation energy requirements with nonthoracotomy internal lead configurations.

METHODS AND RESULTS

A 6/6-millisecond biphasic shock wave-form was delivered via several electrode configurations 10 seconds after ventricular fibrillation was initiated with a 60-Hz generator. In two series, a total of 16 dogs (weight, 23.3 +/- 2.4 kg) underwent an up-down defibrillation protocol. In the first series, the defibrillation threshold (DFT) was determined for each electrode configuration in the presence of two inactive epicardial patches. In the second series, DFTs were determined in the presence of an inactive right ventricular (RV) or left ventricular (LV) patch alone. For several nonthoracotomy lead configurations tested in the first 8 dogs, the mean +/- SD DFT energy increased 49% to 97% with two inactive patches on the heart compared with no patches on the heart as follows: RV to superior vena caval (SVC) electrode, from 8.9 +/- 2.6 to 18.0 +/- 14.3 J; RV to SVC plus subcutaneous array electrode, from 7.0 +/- 2.4 to 10.7 +/- 5.3 J; RV to subcutaneous pectoral plate electrode, from 6.2 +/- 1.3 to 11.4 +/- 4.0 J (P < or = .05). The lowest DFT was achieved by defibrillating between the epicardial patches (3.8 +/- 3.3 J). The second series showed that DFT voltage requirements increased significantly for all three nonthoracotomy lead configurations with the inactive LV patch alone (P < or = .05) but not with the inactive RV patch alone.

CONCLUSIONS

Inactive epicardial patches can significantly increase the defibrillation energy requirements for nonthoracotomy lead configurations. This negative impact may be due to an insulating effect of the patches and to a disturbance of the potential gradient field under the patches. If the same holds true in patients, these results have clinical implications. Functioning epicardial patch leads should be incorporated in the defibrillation lead system if already present. If the LV patch is nonfunctioning, such as because of a lead fracture, the marked increase in DFT due to an inactive LV patch calls for thorough DFT testing during surgery and, in selected patients, may necessitate patch removal to produce an effective transvenous-based system.

Impedance to defibrillation countershock: does an optimal impedance exist?

Defibrillation is thought to occur because of changes in the transmembrane potential that are caused by current flow through the heart tissue. Impedance to electric countershock is an important parameter because it is determined by the magnitude and distribution of the current that flows for a specific shock voltage. The impedance is comprised of resistive contributions from: (1) extra-tissue sources, which include the defibrillator, leads, and electrodes; (2) tissue sources, which include intracardiac and extra-cardiac tissue; and (3) the interface between electrode and tissue. Tissue sources dominate the impedance and probably contribute to the wide range of impedance values presented to the defibrillation pulse. Because impedance is not constant within or between subjects, defibrillators must be designed to accommodate these differences without compromising patient safety or therapeutic efficacy. Experimental investigations in animals and humans suggest that impedance changes at several different time scales ranging from milliseconds to years. These alterations are believed to be a result of both electrochemical and physiological mechanisms. It is commonly thought that impedance is optimized when it has been decreased to a minimum, since this allows the most current flow for a given voltage shock. However, if the impedance is lowered by changing the location or size of the electrodes in such a way that current flow is decreased in part of the heart even though current flow is increased elsewhere, then the total voltage, current, and energy needed for defibrillation may increase, not decrease, even though impedance is decreased. A simple boundary element computer model suggests that the most even distribution of current flow through the heart is achieved for those electrode locations in which the impedance across the heart is at or near the maximum cardiac impedance for any location of these particular electrodes. Thus, the optimum shock impedance is achieved when impedance is minimized for extra-tissue and extra-cardiac tissue sources and is at or near a maximum for intracardiac tissue sources.

Evaluation of impedance cardiography: comparison of NCCOM3-R7 with Fick and thermodilution methods

OBJECTIVE

To assess the degree of error of the BoMed NCCOM3 model revision seven (R7) impedance cardiograph in determining stroke volume and estimated cardiac output.

DESIGN

Three-group, within-subject, repeated measures design.

SAMPLE

Group 1: patients (n = 17) with heart disease undergoing an elective coronary angiogram; group 2: patients (n = 28) after elective heart surgery; and group 3: healthy volunteers (n = 28).

MEASUREMENT

Cardiac output was determined by the BoMed NCCOM3-R7 impedance cardiograph, Fick principle, and thermodilution method. The NCCOM3-R7 was compared with the direct Fick and thermodilution methods in groups 1 and 2, respectively, to estimate validity coefficients. In group 3, repeated measures were obtained with the NCCOM3-R7 to calculate reliability coefficients.

RESULTS

The NCCOM3-R7 underestimated Fick measurements by 1.050 +/- 1.529 L/min at rest and 1.505 +/- 2.214 L/min during exercise. Correlation coefficients of 0.684 at rest (p = 0.001) and 0.219 during exercise (p = 0.248) were obtained. The NCCOM3-R7 underestimated thermodilution values by 0.425 +/- 1.325 L/min in subjects initially after heart surgery and 0.358 +/- 1.235 L/min 2 to 4 hours later. Correlation coefficients of 0.547 (p = 0.002) and 0.505 (p = 0.004) were obtained for the two time periods, respectively. A reliability coefficient of 0.837 was calculated with healthy subjects.

CONCLUSION

The NCCOM3-R7 has a clinically unacceptable level of error for evaluating cardiac performance in patients with heart disease.

A review of impedance cardiography

OBJECTIVE

To review the reliability and validity estimates of impedance cardiography to assess its empirical precision and clinical usefulness.

DATA SOURCE

Empirical and theoretical literature mainly within the last 10 years.

DATA SYNTHESIS

Descriptive statistics used to summarize the accuracy and use of impedance cardiography to estimate stroke volume.

CONCLUSIONS

Estimation of cardiac output is presently a core component of optimizing cardiac function in many patient populations. Impedance cardiography, which initially used a formula developed by Kubicek et al. and recently a formula developed by Sramek and Bernstein, remains controversial with regard to its accuracy and use in research and clinical practice.

The optimal technique for electrical cardioversion of atrial fibrillation

The optimal approach to electrical cardioversion of atrial fibrillation includes appropriate patient selection, anticoagulation, careful selection and monitoring of antiarrhythmic therapy, and proper electrical cardioversion technique. The optimal technique requires the use of metal electrodes, with one electrode of at least 8 cm in diameter placed in the anterior position, and the second of 12-13 cm diameter placed posteriorly just below the left scapulae, with generous amounts of the appropriate gel (such as Hewlett-Packard Redux Paste) as the electrode-skin interface and firm pressure to the paddle electrode with the patient in expiration. Thus the anterior-posterior chest diameter is decreased and less air between the electrodes is assured. The initial shock strength should be 200 J. The shock is synchronized with the electrocardiographic QRS complex. This report reviews the justification for these recommendations.